Dawn Scientific

Dawn Scientific helps life science companies turn complex science and regulation into clear, defensible, and scalable programs. With work across Africa, Asia, Europe, Australia, Latin America, the Caribbean, and North America, we bring real-world experience in complex and emerging markets to guide development from discovery to commercialization. We help innovators de-risk programs, build credible regulatory strategies, and position programs for market and investor confidence. We work with emerging biotechs, growth-stage companies, investors, and global organizations that need to navigate scientific complexity, regulatory risk, and capital challenges without slowing innovation. Our expertise spans the pharmaceutical and biotechnology industries, psychedelics, and other controlled substances. We focus on programs that demand rigorous science, precise regulatory strategy, and strong investor positioning. Core Services: - Innovation planning to advance scientific concepts into market-ready programs - Integrated drug development and clinical trial design - Regulatory submissions, briefing packages, and expert opinion support - Formulation development for complex and regulated compounds - DEA and controlled substance regulatory guidance and compliance - Capital planning, scientific due diligence, and investor engagement - Fractional and interim scientific and regulatory leadership Our work has supported programs achieving regulatory clearance, securing investor funding, expanding into new markets, and advancing innovative therapeutics from early discovery to late-stage development. Built on multidisciplinary science and global regulatory experience, Dawn Scientific transforms complexity into progress and delivers strategies that move programs from molecule to market with integrity.